Cargando…

Loss of heterozygosity on chromosomes 11 and 17 are markers of recurrence in TCC of the bladder

Approximately 2/3 of patients diagnosed with superficial transitional cell carcinoma of the urinary bladder (TCC) will recur within 2 years. Loss of chromosome 9 and loss of heterozygosity (LOH) at 9q34 in index TCCs identify a subset of patients at high risk of recurrence. This study explores genet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Edwards, J, Duncan, P, Going, J J, Grigor, K M, Watters, A D, Bartlett, J M S
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2001
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364026/ https://www.ncbi.nlm.nih.gov/pubmed/11747332 http://dx.doi.org/10.1054/bjoc.2001.2159

Ejemplares similares

Is chromosome 9 loss a marker of disease recurrence in transitional cell carcinoma of the urinary bladder?
por: Bartlett, J. M., et al.
Publicado: (1998)

Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix.
por: Kersemaekers, A. M., et al.
Publicado: (1998)

Loss of constitutional heterozygosity on chromosomes 5 and 17 in cholangiocarcinoma.
por: Ding, S. F., et al.
Publicado: (1993)

Frequent loss of heterozygosity on chromosome 17 at 17q11.2-q12 in Barrett's adenocarcinoma.
por: Swift, A., et al.
Publicado: (1995)

Loss of heterozygosity on chromosomes 1 and 11 in carcinoma of the pancreas.
por: Ding, S. F., et al.
Publicado: (1992)

Loss of heterozygosity at chromosome 1p in different solid human tumours: association with survival
por: Ragnarsson, G, et al.
Publicado: (1999)

Loss of heterozygosity on the long arm of chromosome 11 in colorectal tumours.
por: Gustafson, C. E., et al.
Publicado: (1994)

Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines
por: Tilborg, A A G van, et al.
Publicado: (1999)

Loss of heterozygosity and amplification on chromosome 11q in human ovarian cancer.
por: Foulkes, W. D., et al.
Publicado: (1993)

High rates of loss of heterozygosity on chromosome 19p13 in human breast cancer
por: Oesterreich, S, et al.
Publicado: (2001)

Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan
por: Sheu, J-C, et al.
Publicado: (1999)

Loss of heterozygosity at 18q21 is indicative of recurrence and therefore poor prognosis in a subset of colorectal cancers
por: Jernvall, P, et al.
Publicado: (1999)

Paraneoplastic Hypercalcaemia Associated with TCC of Bladder
por: Patel, A. B., et al.
Publicado: (2004)

Prognostic significance of loss of heterozygosity at loci on chromosome 17p13.3-ter in sporadic breast cancer is evidence for a putative tumour suppressor gene
por: Liscia, D S, et al.
Publicado: (1999)

Loss of heterozygosity at chromosome 11 in breast cancer: association of prognostic factors with genetic alterations.
por: Gudmundsson, J., et al.
Publicado: (1995)

Candidate target genes for loss of heterozygosity on human chromosome 17q21
por: DeMarchis, L, et al.
Publicado: (2004)

Candidate target genes for loss of heterozygosity on human chromosome 17q21
por: DeMarchis, L, et al.
Publicado: (2004)

Loss of heterozygosity in the Hodgkin-Reed Sternberg cell line L1236
por: Staratschek-Jox, A, et al.
Publicado: (2001)

Loss of heterozygosity occurs at the D11S29 locus on chromosome 11q23 in invasive cervical carcinoma.
por: Bethwaite, P. B., et al.
Publicado: (1995)

Loss of heterozygosity on chromosome 18q is associated with muscle-invasive transitional cell carcinoma of the bladder.
por: Brewster, S. F., et al.
Publicado: (1994)

Loss of heterozygosity on chromosome 16 in sporadic Wilms' tumour.
por: Grundy, R. G., et al.
Publicado: (1998)

Loss of heterozygosity at 7p in Wilms' tumour development
por: Powlesland, R M, et al.
Publicado: (2000)

Genomic alterations associated with loss of heterozygosity for TP53 in Li-Fraumeni syndrome fibroblasts
por: Burt, E C, et al.
Publicado: (2000)

Neuroendocrine Carcinoma of the Kidney and Bladder with Loss of Heterozygosity and Changes in Chromosome 3 Copy Number
por: Okada, Atsushi, et al.
Publicado: (2015)

Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma.
por: Foulkes, W. D., et al.
Publicado: (1993)

Loss of chromosome 11q21–23.1 and 17p and gain of chromosome 6p are independent prognostic indicators in B-cell non-Hodgkin's lymphoma
por: Stokke, T, et al.
Publicado: (2001)

Loss of heterozygosity is related to p53 mutations and smoking in lung cancer
por: Zienolddiny, S, et al.
Publicado: (2001)

Loss of heterozygosity (LOH), malignancy grade and clonality in microdissected prostate cancer
por: Hügel, A, et al.
Publicado: (1999)

p53 Gene Mutation and Loss of Heterozygosity of Chromosome 11 in Methylcholanthrene‐induced Mouse Sarcomas
por: Shimokado, Kiyoshi, et al.
Publicado: (1998)

Mutation analysis of the Fanconi anaemia A gene in breast tumours with loss of heterozygosity at 16q24.3
por: Cleton-Jansen, A-M, et al.
Publicado: (1999)

List of TCC documents
por: CERN. Geneva. Track Chamber Committee
Publicado: (1976)

Loss of heterozygosity on chromosome 10, 13q(Rb), 17p, and p53 gene mutations in human brain gliomas.
por: Lee, S. H., et al.
Publicado: (1995)

Loss of constitutional heterozygosity on chromosome 5q in hepatocellular carcinoma without cirrhosis.
por: Ding, S. F., et al.
Publicado: (1991)

Evaluation of loss of heterozygosity of chromosome 22q11.21 region in patients with congenital heart diseases
por: Behiry, Eman G., et al.
Publicado: (2018)

Loss of heterozygosity at chromosome 6q in preinvasive and early invasive breast carcinomas.
por: Chappell, S. A., et al.
Publicado: (1997)

Chemotherapy induced microsatellite instability and loss of heterozygosity in chromosomes 2, 5, 10, and 17 in solid tumor patients
por: Kamat, Nasir, et al.
Publicado: (2014)

Loss-of-heterozygosity on chromosome 19q in early-stage serous ovarian cancer is associated with recurrent disease
por: Skirnisdottir, Ingiridur, et al.
Publicado: (2012)

Detection of functional PTEN lipid phosphatase protein and enzyme activity in squamous cell carcinomas of the head andeck, despite loss of heterozygosity at this locus
por: Snaddon, J, et al.
Publicado: (2001)

New Strategies in the Treatment of Ta-T1 Transitional Cell Carcinoma (TCC) of the Bladder
por: Brausi, Maurizio A.
Publicado: (2006)

Deletion of WT1 and WIT1 Genes and Loss of Heterozygosity on Chromosome 11p in Wilms Tumors in Japan
por: Kaneko, Yasuhiko, et al.
Publicado: (1993)

Cannot write session to /tmp/vufind_sessions/sess_vdqh3cq810lle4rtjhhu0ucbeq